SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing a significant rally following a CMS announcement that finalizes 2027 Medicare Advantage payment rates at a higher-than-expected increase, alleviating major industry uncertainty. The community is actively debating the sustainability of these gains, with many investors viewing the news as a long-awaited relief catalyst while others remain cautious of ongoing sector volatility and regulatory headwinds.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is currently seeing intense debate among investors as the stock faces downward pressure, with bears highlighting concerns over certification timelines, testing delays, and competitive challenges in the eVTOL space. Meanwhile, bulls continue to emphasize the company's long-term potential, citing strategic partnerships and upcoming operational milestones as catalysts that could drive a significant recovery.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing significant downward pressure as investors react to a debt offering, raising concerns over the company's financial leverage and capital management. Meanwhile, the community remains deeply divided, with some traders betting on further downside due to fundamental weaknesses while others identify the sharp sell-off as a potential deep-value opportunity.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is facing intense community debate as investors weigh significant insider stock purchases by leadership against concerns regarding high short interest and potential volatility following the expiration of lock-up periods. While some participants are betting on a short squeeze driven by dwindling share availability, others remain cautious, focusing on the company's path to profitability and upcoming legal catalysts.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is experiencing significant volatility and downward pressure following a recent reverse stock split, sparking intense debate among community members who are split between betting on a potential short squeeze and warning of further downside. Traders are actively monitoring management's silence on guidance and the stock's proximity to pre-split lows, with many users expressing frustration over long-term performance while others hunt for technical entry points.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is under intense community scrutiny following a significant patent infringement loss in China's Supreme Court, fueling speculation about a potential billion-dollar settlement with Xiao-I AI. While traders remain wary of the stock's recent performance compared to broader tech peers, the community is actively debating whether Apple will move to settle the legal dispute quickly to avoid further disruptions to its Chinese operations.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is facing significant downward pressure following the release of Phase 3 clinical trial data for its thyroid eye disease candidate, elegrobart, which investors deemed underwhelming compared to Amgen's established Tepezza. While some analysts maintain a bullish long-term outlook citing potential differentiation in dosing and subcutaneous delivery, the market is currently reacting with heavy put-option hedging and skepticism regarding the treatment's competitive profile.

Taseko Mines Ltd. operates as a mining company which engages in the acquisition, development, and operation of mineral deposits. It holds interest in the Gibraltar, Florence Copper, Aley Niobium, Yellowhead, New Prosperity, and Harmony projects. The company was founded on April 15, 1966 and is headquartered in Vancouver, Canada.

Taseko Mines Ltd.

Taseko Mines is trending as investors bet on the companys transition into a major U.S. copper producer, with the Florence Copper project nearing commercial production and poised to double output. The community is actively discussing the potential for a structural copper supply shortage, the strategic importance of North American assets for AI and green energy, and the stock's significant upside potential as it moves toward operational milestones.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is trending as investors weigh its potential role in the Co-Packaged Optics supply chain for AI data centers against persistent concerns over weak legacy display driver demand. The community remains divided, with some betting on a long-term turnaround fueled by strategic partnerships, while others express frustration over stagnant performance and repetitive earnings narratives.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending following the acquisition of StereoLabs, a move that positions the company as a leader in physical AI by unifying lidar hardware with advanced stereo vision and AI perception software. Investors are focused on the strategic expansion into robotics and industrial sectors, alongside the combined company's positive EBITDA path and access to a significantly larger customer base.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Third Harmonic Bio, Inc. (THRD) drew investor attention on Monday after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.thirdharmonicbio.com/news-releases/news-release-details/third-harmonic-bio-announces-plan-liquidation-and-dissolution">announced </a>that its board of directors has approved a plan for the liquidation and dissolution of the firm and the distribution of remaining cash to stockholders.The company plans to file a certification of dissolution with the Secretary of the State of Delaware in the third quarter of 2025, provided that stockholders authorize the decision at their annual meeting on June 5.The company will subsequently delist its shares of common stock from Nasdaq.Third Harmonic Bio CEO said that after reviewing strategic alternatives, the management team and board of directors determined that returning cash to shareholders and selling its assets is the “best path forward.”The company expects that its existing capital resources, coupled with the anticipated net proceeds from the sale of certain clinical assets, will enable it to meet its remaining liabilities and obligations with sufficient reserves.The company estimates that the initial distribution will be between approximately $246.6 million and $255.4 million, or approximately $5.13 and $5.33 per share of common stock. The amount will be distributed after the company files for dissolution in the third quarter.It added that the estimates do not include any cash that may become available for distribution following sales of the company’s assets.The company said that it will complete all Phase 2 readiness activities for its lead product candidate THB335, aimed at treating chronic spontaneous urticaria, by mid-year to maximize the program's value, which will be sold as part of the dissolution plan.Following the announcement, shares of the company rocketed over 39% in Monday’s pre-market session.On Stocktwits, retail sentiment around Third Harmonic Bio fell from ‘neutral’ to ‘extremely bearish’ over the past 24 hours while message volume rose from ‘extremely low’ to ‘extremely high.’<figure class="image"><img style="aspect-ratio:650/149;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_14_at_7_59_17_AM_png_4ae3a9f87c.webp" alt="THRD's Sentiment Meter and Message Volume as of 8:05 a.m. ET on April 14, 2025 | Source: Stocktwits" width="650" height="149"><figcaption>THRD's Sentiment Meter and Message Volume as of 8:05 a.m. ET on April 14, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/THRD">THRD stock</a> fell by about 67% year-to-date and by 69% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/pfizer-ends-development-of-weight-loss-pill-danuglipron/chfCPelRba2">Pfizer Ends Development Of Weight Loss Pill Due To Potential Drug-Induced Liver Injury In A Patient</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered

The company plans to file a certification of dissolution with the Secretary of the State of Delaware in the third quarter of 2025, provided that stockholders authorize the decision at its annual meeting of stockholders on June 5.

Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 38% Pre-Market, But Retail’s Shattered

Equity

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. The company was founded on April 25, 2019 and is headquartered in San Francisco, CA.

THRD
THIRD HARMONIC BIO INC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest THRD News

THRDTHIRD HARMONIC BIO INC